+

WO2000037100A3 - Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux - Google Patents

Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux Download PDF

Info

Publication number
WO2000037100A3
WO2000037100A3 PCT/CA1999/001225 CA9901225W WO0037100A3 WO 2000037100 A3 WO2000037100 A3 WO 2000037100A3 CA 9901225 W CA9901225 W CA 9901225W WO 0037100 A3 WO0037100 A3 WO 0037100A3
Authority
WO
WIPO (PCT)
Prior art keywords
reducing
fish
birds
compositions
methods
Prior art date
Application number
PCT/CA1999/001225
Other languages
English (en)
Other versions
WO2000037100A2 (fr
Inventor
Robert Brown
Bill Pohajdak
Warwick Charles Kimmins
Janet Horrocks
Leslie Maclaren
Original Assignee
Univ Dalhousie
Robert Brown
Bill Pohajdak
Warwick Charles Kimmins
Janet Horrocks
Leslie Maclaren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Dalhousie, Robert Brown, Bill Pohajdak, Warwick Charles Kimmins, Janet Horrocks, Leslie Maclaren filed Critical Univ Dalhousie
Priority to EP99960753A priority Critical patent/EP1140151A2/fr
Priority to CA002356452A priority patent/CA2356452A1/fr
Priority to AU17653/00A priority patent/AU1765300A/en
Priority to US09/868,983 priority patent/US6790457B1/en
Publication of WO2000037100A2 publication Critical patent/WO2000037100A2/fr
Publication of WO2000037100A3 publication Critical patent/WO2000037100A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Cette invention se rapporte à une composition de vaccin immunocontraceptif, qui comprend un homologue téléostéen de zona pellucida (TH-ZP), associé à un diluant ou excipient acceptable sur le plan pharmaceutique, en vue de réduire ou de prévenir la fertilisation chez un poisson, ainsi qu'à un procédé d'utilisation de cette composition. Cette invention se rapporte également à une composition de vaccin immunocontraceptif, qui comprend un antigène provenant d'une couche périvitelline interne (IPVL), associé à un diluant ou excipient acceptable sur le plan pharmaceutique, en vue de réduire ou de prévenir la fertilisation chez un oiseau, ainsi qu'à un procédé d'utilisation de cette composition.
PCT/CA1999/001225 1998-12-22 1999-12-22 Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux WO2000037100A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP99960753A EP1140151A2 (fr) 1998-12-22 1999-12-22 Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux
CA002356452A CA2356452A1 (fr) 1998-12-22 1999-12-22 Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux
AU17653/00A AU1765300A (en) 1998-12-22 1999-12-22 Compositions and methods for reducing or preventing fertilization in fish and birds
US09/868,983 US6790457B1 (en) 1998-12-22 1999-12-22 Compositions and methods for reducing or preventing fertilization in fish and birds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11352698P 1998-12-22 1998-12-22
US60/113,526 1998-12-22

Publications (2)

Publication Number Publication Date
WO2000037100A2 WO2000037100A2 (fr) 2000-06-29
WO2000037100A3 true WO2000037100A3 (fr) 2000-12-07

Family

ID=22349942

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1999/001225 WO2000037100A2 (fr) 1998-12-22 1999-12-22 Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux

Country Status (4)

Country Link
EP (1) EP1140151A2 (fr)
AU (1) AU1765300A (fr)
CA (1) CA2356452A1 (fr)
WO (1) WO2000037100A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9498493B2 (en) 2007-09-27 2016-11-22 Immunovaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2378472A1 (fr) * 1999-07-01 2001-01-11 The University Of Georgia Research Foundation, Inc. Procede et composition permettant d'affecter les systemes de reproduction
ATE317267T1 (de) * 2000-11-07 2006-02-15 Immunovaccine Technologies Inc Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
WO2003101482A2 (fr) * 2002-05-31 2003-12-11 Genesis Group Inc. Formulations de vaccins associes a des liposomes, destinees a des poissons a nageoires
CA2523032A1 (fr) 2005-10-07 2007-04-07 Immunovaccine Technologies Inc. Vaccins pour la therapie du cancer
US20110070298A1 (en) 2008-06-05 2011-03-24 Immunovaccine Technologies Inc. Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance
IN2014CN02581A (fr) 2011-10-06 2015-08-07 Immunovaccine Technologies Inc
GB201204280D0 (en) 2012-03-09 2012-04-25 Univ Nordland Methods

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012247A1 (fr) * 1991-01-09 1992-07-23 Proteus Molecular Design Limited Analogues de lhrh de poisson
WO1993025231A1 (fr) * 1992-06-05 1993-12-23 Dalhousie University Utilisation de glycoproteines de la zone pellucide dans l'immunocontraception
US5656488A (en) * 1990-11-21 1997-08-12 Washington University Recombinant avirulent salmonella antifertility vaccines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656488A (en) * 1990-11-21 1997-08-12 Washington University Recombinant avirulent salmonella antifertility vaccines
WO1992012247A1 (fr) * 1991-01-09 1992-07-23 Proteus Molecular Design Limited Analogues de lhrh de poisson
WO1993025231A1 (fr) * 1992-06-05 1993-12-23 Dalhousie University Utilisation de glycoproteines de la zone pellucide dans l'immunocontraception

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHANG Y.S. ET AL: "Molecular cloning, structural analysis and expression of carp ZP2 gene", MOLECULAR REPRODUCTION AND DEVELOPMENT, vol. 46, 1997, pages 258 - 267, XP000891751 *
CHANG Y.S. ET AL: "Molecular cloning, structural analysis and expression of carp zp3 gene", MOLECULAR REPRODUCTION AND DEVELOPMENT, vol. 44, 1996, pages 295 - 304, XP000891769 *
DATABASE SCISEARCH [online] MOCHIDA K ET AL: "SPERM INFERTILITY CAUSED BY EXPERIMENTAL TESTICULAR AUTOIMMUNITY IN THE NILE TILAPIA", XP002134944, retrieved from STN Database accession no. 159365 *
HINDS LYN A ET AL: "Immuno-contraceptive control for carp.", 1997, WORKSHOP;ALBURY, NEW SOUTH WALES, AUSTRALIA; OCTOBER 22-24, 1996, CONTROLLING CARP: EXPLORING THE OPTIONS FOR AUSTRALIA. 1997 CSIRO PUBLICATIONS 314 ALBERT STREET, EAST MELBOURNE, VICTORIA, AUSTRALIA, PAGE(S) 108-118, ISBN: 0-643-05883-4, XP000879881 *
HJERTEN S ET AL: "Studies of fish zona pellucida by high-performance ion-exchange chromatography on agarose columns and free zone electrophoresis", JOURNAL OF CHROMATOGRAPHY BIOMEDICAL APPLICATIONS, vol. 341, 1985, pages 295 - 304, XP000891408 *
NIPPON SUISAN GAKKAISHI-BULLETIN OF THE JAPANESE SOCIETY OF SCIENTIFIC FISHERIES, (FEB 1993) VOL. 59, NO. 2, PP. 253-261. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9498493B2 (en) 2007-09-27 2016-11-22 Immunovaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo

Also Published As

Publication number Publication date
EP1140151A2 (fr) 2001-10-10
AU1765300A (en) 2000-07-12
CA2356452A1 (fr) 2000-06-29
WO2000037100A2 (fr) 2000-06-29

Similar Documents

Publication Publication Date Title
MX9705710A (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
WO2000037100A3 (fr) Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux
EP1686120A3 (fr) Procédés et compositions utilisant des quinazolinones
FR2784296B1 (fr) Dispositif pour la formulation et la delivrance d'un melange, notamment pour l'application chirurgicale de ce melange
DE60023841D1 (de) Verfahren zur herstellung alkylierter salicylamide
CA2455134A1 (fr) Adjuvants pour vaccins
AP9801384A0 (en) Improvements of implantation rates after in vitro fertilization.
WO2003077733A3 (fr) Methode et appareil permettant d'acceder a l'appendice auriculaire gauche
WO2004053056A3 (fr) Systeme d'administration de vaccin a base de nanoparticules contenant un adjuvant
WO2004026113A3 (fr) Dispositif et procede de reduction des pertes de fluide lors d'une procedure chirurgicale
DE60034662D1 (de) Behandlung von unfruchtbarkeit
WO2000013650A3 (fr) Neuroprotection
WO2002022523A3 (fr) Procedes et melanges de traitement d'arbres abimes
WO2001008695A3 (fr) Utilisation d'agonistes et/ou d'antagonistes de l'amh pour la regulation a long terme de la fertilite feminine
ATE473732T1 (de) Biosicherheitssytem
WO2004024237A3 (fr) Methode de sterilisation au moyen de materiaux se gelifiant in situ
ATE384085T1 (de) Alpha olefin monomer enthaltendes trennmittel zur herstellung von viskositätsvermindernden mitteln und verfahren zur herstellung von viskositätsvermindernden mitteln unter verwendung von alpha olefin monomer enthaltenden trennmitteln
DE69623652D1 (de) Formulierung zur peptidfreisetzung
EP1209914A3 (fr) Appareil et méthode pour créer du contenu pour diffusion
WO1999020223A3 (fr) Antagonistes de l'hormone luteinisante utiles pour le traitement de carences oestrogeniques ou utilises en tant que contraceptif
NZ330603A (en) Hyaluronic acid derivatives used as cervical ripening agents
WO2001002000A3 (fr) Procede et composition permettant d'affecter les systemes de reproduction
AU2002220492A1 (en) Method for inducing onset of the reproductive cycle of female breeding animals
WO2002024147A3 (fr) Vaccin contre le pneumovirus aviaire
AU5781300A (en) Fertility impairing vaccine containing avian zona pellucida protein and method of use

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2000 17653

Country of ref document: AU

Kind code of ref document: A

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2356452

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2356452

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1999960753

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999960753

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09868983

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1999960753

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载